BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 12418674)

  • 21. Robert Koch redux: malaria immunology in Papua New Guinea.
    Stanisic DI; Mueller I; Betuela I; Siba P; Schofield L
    Parasite Immunol; 2010 Aug; 32(8):623-32. PubMed ID: 20626817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the prevalence of malaria in rural Papua New Guinea using a geographic information system.
    Namosha E; Mueller I; Kastens W; Kiele R; Kasehagen L; Siba PM
    P N G Med J; 2010; 53(1-2):5-14. PubMed ID: 22768474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bibliometrics of global malaria vaccine research.
    Garg KC; Kumar S; Madhavi Y; Bahl M
    Health Info Libr J; 2009 Mar; 26(1):22-31. PubMed ID: 19245640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex patterns of malaria epidemiology in the highlands region of Papua New Guinea.
    Mueller I; Taime J; Ibam E; Kundi J; Lagog M; Bockarie M; Reeder JC
    P N G Med J; 2002; 45(3-4):200-5. PubMed ID: 12968790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome for children with bacterial meningitis in rural Papua New Guinea.
    Wandi F; Kiagi G; Duke T
    J Trop Pediatr; 2005 Feb; 51(1):51-3. PubMed ID: 15601647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceptions of malaria and vaccines in Kenya.
    Ojakaa D; Yamo E; Collymore Y; Ba-Nguz A; Bingham A
    Hum Vaccin; 2011 Oct; 7(10):1096-9. PubMed ID: 21941095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemic malaria in the highlands of Papua New Guinea.
    Mueller I; Namuigi P; Kundi J; Ivivi R; Tandrapah T; Bjorge S; Reeder JC
    Am J Trop Med Hyg; 2005 May; 72(5):554-60. PubMed ID: 15891129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical malaria vaccine development.
    Sauerwein RW
    Immunol Lett; 2009 Feb; 122(2):115-7. PubMed ID: 19100773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress with new malaria vaccines.
    Webster D; Hill AV
    Bull World Health Organ; 2003; 81(12):902-9. PubMed ID: 14997243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria control in Papua New Guinea results in complex epidemiological changes.
    Mueller I; Tulloch J; Marfurt J; Hide R; Reeder JC
    P N G Med J; 2005; 48(3-4):151-7. PubMed ID: 17212061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Vaccine Initiative: lessons from developing malaria vaccines.
    Geels MJ; Imoukhuede EB; Imbault N; van Schooten H; McWade T; Troye-Blomberg M; Dobbelaer R; Craig AG; Leroy O
    Expert Rev Vaccines; 2011 Dec; 10(12):1697-708. PubMed ID: 22085173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy challenges in malaria vaccine introduction.
    Moree M; Ewart S
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):248-52. PubMed ID: 15331844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health research in Papua New Guinea.
    Reeder JC
    Trends Parasitol; 2003 Jun; 19(6):241-5. PubMed ID: 12798079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of malaria in the Papua New Guinea highlands: 1. Western Highlands Province.
    Mueller I; Taime J; Ivivi R; Yala S; Bjorge S; Riley ID; Reeder JC
    P N G Med J; 2003; 46(1-2):16-31. PubMed ID: 16450780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The crisis of measles and the need to expand the ways of delivering vaccines in Papua New Guinea.
    Duke T
    P N G Med J; 2003; 46(1-2):1-7. PubMed ID: 16450778
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-sectional characterization of malaria in Sanma and Shefa Provinces, Republic of Vanuatu: malaria control implications.
    Maguire JD; Bangs MJ; Brennan L; Rieckmann K; Taleo G
    P N G Med J; 2006; 49(1-2):22-31. PubMed ID: 18396609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inadequate chemoprophylaxis and the risk of malaria.
    Massey P; Durrheim DN; Speare R
    Aust Fam Physician; 2007 Dec; 36(12):1058-60. PubMed ID: 18075636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Australasian contribution to malaria vaccine development.
    Redmond AM; Doolan DL
    Parasite Immunol; 2010 Aug; 32(8):607-22. PubMed ID: 20626816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malaria in developing countries.
    López Del Prado GR; Hernán García C; Moreno Cea L; Fernández Espinilla V; Muñoz Moreno MF; Delgado Márquez A; Polo Polo MJ; Andrés García I
    J Infect Dev Ctries; 2014 Jan; 8(1):1-4. PubMed ID: 24423706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria vaccines in development.
    Ballou WR
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):489-503. PubMed ID: 16083325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.